Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celgosivir + SOC in Treatment-Naïve Chronic Hepatitis C
NCT00332176Phase 2Unknown
- Sponsor
- BioWest Therapeutics
- Start
- Jun 2006
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of celgosivir in hepatitis C (HCV), sponsored by BioWest Therapeutics. Status: unknown.
02
Drugs
celgosivir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00332176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00332176.